CMS Finalizes Oversight Rule for Organ Procurement
The new federal policy aims to boost transplant rates and increase accountability for organ procurement organizations.
Updated on Oct. 30, 2026 in Nursing Jobs
Live Poll
Should the government increase oversight of organ procurement organizations to improve transplant access?
The Centers for Medicare and Medicaid Services has finalized a rule to strengthen oversight of organ procurement organizations across the United States. The policy aims to ensure more donated organs reach the over 100,000 Americans currently awaiting lifesaving transplants.
Why it matters
By allowing high-performing organizations to compete for multiple service areas, the rule seeks to increase efficiency and accountability in the national organ donation system. This follows a period of growth that saw donation and transplant volumes rise significantly since 2020.
Since 2020, organ donations have increased by 36% nationwide, while the total volume of transplants grew by 30%. Currently, there are more than 100,000 Americans waiting for an organ transplant in the United States.
The players
Centers for Medicare and Medicaid Services
This federal agency within the United States Department of Health and Human Services administers programs including Medicare, Medicaid, and the Children's Health Insurance Program.
President Donald Trump
Serving as the current President of the United States, he previously issued an executive order in 2019 to advance kidney health, which initiated a focus on organ procurement reforms.
The details
The rule mandates that medical directors for these organizations must hold a license in at least one state or territory where they operate. Additionally, organizations are now required to track the final disposition of organs sent for research, with pancreata used strictly for islet cell research excluded from performance counts.
Timeline
2019: President Donald Trump issued the Executive Order on Advancing American Kidney Health.
2020: CMS issued an OPO rule establishing the initial performance measures.
2025: The United States performed over 49,000 organ transplants.
October 30, 2026: CMS finalized the current oversight rule for organ procurement organizations.
Market Landscape
The new regulation updates and strengthens the performance accountability framework established by the 2020 OPO rule. By introducing competitive bidding for service areas, the CMS is shifting the market toward a performance-based model that prioritizes transplant throughput.
For patients awaiting transplants, this rule intends to reduce wait times by ensuring that organizations are held to higher performance standards and operational efficiency. Potential donors and families should see greater transparency regarding how donated organs are allocated and tracked for research versus medical use.
The takeaway
The new CMS rule marks a significant transition toward a more competitive and data-driven approach to organ procurement. Stakeholders and organizations must now prepare to meet heightened accountability standards to maintain their service area designations.
Further reading
Learn more about the evolving healthcare workforce by visiting United States Nursing Jobs.
More information
View the final rule in federal register for complete regulatory details.
Live Poll
Should the government increase oversight of organ procurement organizations to improve transplant access?
